Get the Stockscreener App
3.28
3.80%
0.12
After Hours:
3.34
0.06
+1.83%
Voyager Therapeutics Inc Stock (VYGR) Forecast
The Voyager Therapeutics Inc (VYGR) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.9161, representing a -72.07% decrease from the current price of $3.28. The highest analyst price target is $0.8871, and the lowest is $0.9451.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VYGR Price Target
Average 4.073
(+24.18% Upside)
Is Voyager Therapeutics Inc (VYGR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.09 | Neutral |
| STOCH(9,6) | 26.94 | Neutral |
| STOCHRSI(14) | 40.02 | Neutral |
| MACD(12,26) | 0.0122 | Sell |
| ADX(14) | 13.75 | Neutral |
| William %R | -61.11 | Neutral |
| CCI(14) | -13.40 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.2885
Sell
|
3.2369
Buy
|
| MA20 |
3.2038
Buy
|
3.2268
Buy
|
| MA50 |
3.1934
Buy
|
3.271
Buy
|
| MA100 |
3.3841
Sell
|
3.6147
Sell
|
| MA200 |
4.6663
Sell
|
4.5648
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, VYGR could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on VYGR, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 52.09 indicates that VYGR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 26.94 indicates that VYGR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 40.02 indicates that VYGR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.75 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -13.4 indicates that VYGR is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term VYGR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Voyager Therapeutics Inc financial reports and earnings history, Voyager Therapeutics Inc (VYGR) stock could reach $7.9924 by 2030, $15.23 by 2040 and $47.06 by 2050. See the projected annual prices until 2050 of the Voyager Therapeutics Inc stock below:
- Voyager Therapeutics Inc (VYGR) is expected to reach an average price of $6.1819 in 2035, with a high prediction of $6.6695 and a low estimate of $6.3919. This indicates an $88.47% rise from the last recorded price of $3.28.
- Voyager Therapeutics Inc (VYGR) stock is projected to chart a bullish course in 2040, with an average price target of $15.94, representing an $385.83% surge from its current level. The forecast ranges from a conservative $15.63 to a sky-high $15.23.
- Our analysts predict Voyager Therapeutics Inc (VYGR) to jump 797.55% by 2045, soaring from $29.72 to an average price of $29.44, potentially reaching $29.38. While $29.72 is the low estimate, the potential upside is significant.
- Voyager Therapeutics Inc (VYGR) stock is expected to climb by 2050, reaching an average of $42.72, a $1,202% jump from its current level. However, a wide range of estimates exists, with high and low targets of $47.06 and $45.00, respectively, highlighting the market's uncertainty.
Voyager Therapeutics Inc Stock (VYGR) Year by Year Forecast
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2025
Voyager Therapeutics Inc Stock (VYGR) is expected to reach an average price of $3.5016 in 2025, with a high prediction of $6.0582 and a low estimate of $0.9451. This indicates an +6.76% rise from the last recorded price of $3.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2025 | $0.7151 | $0.9451 | $0.8871 | -78.20% |
| September, 2025 | $2.2912 | $1.5491 | $2.0812 | -30.15% |
| October, 2025 | $2.5315 | $1.6974 | $1.6453 | -22.82% |
| November, 2025 | $2.4876 | $2.1936 | $2.4704 | -24.16% |
| December, 2025 | $2.3479 | $2.0938 | $2.2617 | -28.42% |
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2026
The predicted value for Voyager Therapeutics Inc (VYGR) in 2026 is set at an average of $5.4709. Estimates vary from a peak of $8.2199 to a trough of $2.7219, indicating an +66.80% surge from the present price of $3.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.374 | $2.7219 | $4.054 | +33.35% |
| February, 2026 | $3.9302 | $4.5602 | $4.3662 | +19.82% |
| March, 2026 | $4.0464 | $4.4463 | $4.5283 | +23.37% |
| April, 2026 | $5.6266 | $4.1404 | $4.9466 | +71.54% |
| May, 2026 | $6.6828 | $6.7307 | $6.3228 | +103.74% |
| June, 2026 | $7.319 | $7.3649 | $7.2009 | +123.14% |
| July, 2026 | $7.3392 | $7.2511 | $7.1971 | +123.76% |
| August, 2026 | $7.0254 | $7.5254 | $7.4713 | +114.19% |
| September, 2026 | $7.6656 | $7.3494 | $7.4556 | +133.71% |
| October, 2026 | $8.1168 | $8.1697 | $8.1677 | +147.46% |
| November, 2026 | $8.028 | $8.218 | $8.2199 | +144.76% |
| December, 2026 | $8.4782 | $7.992 | $8.0782 | +158.48% |
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Voyager Therapeutics Inc (VYGR) is $5.1799, with a high forecast of $8.4122 and a low forecast of $1.9476. This indicates an +57.92% increase from the last price of $3.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.1644 | $6.9403 | $8.4122 | +118.43% |
| February, 2027 | $7.5305 | $7.3625 | $7.3155 | +129.59% |
| March, 2027 | $7.6508 | $7.8185 | $7.6086 | +133.26% |
| April, 2027 | $7.557 | $7.737 | $7.6189 | +130.39% |
| May, 2027 | $7.1131 | $7.5591 | $7.461 | +116.86% |
| June, 2027 | $6.4734 | $6.4893 | $6.7672 | +97.36% |
| July, 2027 | $2.4095 | $2.4055 | $3.2574 | -26.54% |
| August, 2027 | $2.4057 | $1.9476 | $1.5317 | -26.65% |
| September, 2027 | $3.6559 | $3.0798 | $3.2929 | +11.46% |
| October, 2027 | $4.5621 | $3.72 | $4.1621 | +39.09% |
| November, 2027 | $2.8483 | $3.5183 | $3.3862 | -13.16% |
| December, 2027 | $3.1685 | $2.9445 | $2.3623 | -3.40% |
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2028
In 2028, Voyager Therapeutics Inc (VYGR) is projected to reach an average price of $3.3903, with a high projection of $6.7552 and a low estimate of $0.0253. This indicates an +3.36% rise from the last price of $3.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.4747 | $3.2447 | $3.0426 | -24.55% |
| February, 2028 | $3.0309 | $2.654 | $2.4168 | -7.60% |
| March, 2028 | $3.5911 | $3.159 | $3.3811 | +9.48% |
| April, 2028 | $3.1173 | $3.5273 | $3.1992 | -4.96% |
| May, 2028 | $2.8875 | $2.6994 | $2.6513 | -11.97% |
| June, 2028 | $0.8563 | $0.4563 | $2.5113 | -73.89% |
| July, 2028 | $0.4499 | $0.4458 | $1.4182 | -86.28% |
| August, 2028 | $0.4601 | $0.7839 | $0.677 | -85.97% |
| September, 2028 | $0.1537 | $0.2963 | $0.5359 | -95.31% |
| October, 2028 | $0.3675 | $0.0253 | $0.5837 | -88.79% |
| November, 2028 | $3.8473 | $0.1835 | $6.7552 | +17.30% |
| December, 2028 | $4.0811 | $3.4452 | $6.6652 | +24.43% |
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2029
The 2029 price forecast for Voyager Therapeutics Inc Stock (VYGR) is $3.4742 on average, with a high prediction of $6.8901 and a low estimate of $0.0583. This represents an +5.92% increase from the previous price of $3.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.1309 | $1.405 | $4.2421 | -35.03% |
| February, 2029 | $2.6447 | $1.4228 | $2.7447 | -19.37% |
| March, 2029 | $1.0586 | $1.0286 | $3.3166 | -67.73% |
| April, 2029 | $0.6324 | $0.0864 | $1.4245 | -80.72% |
| May, 2029 | $0.2278 | $0.0583 | $1.1083 | -93.05% |
| June, 2029 | $1.176 | $0.1141 | $1.246 | -64.15% |
| July, 2029 | $2.1498 | $0.8479 | $2.5898 | -34.46% |
| August, 2029 | $1.1596 | $0.8277 | $5.4658 | -64.65% |
| September, 2029 | $2.2134 | $1.0774 | $2.2734 | -32.52% |
| October, 2029 | $3.2232 | $2.3453 | $4.7832 | -1.73% |
| November, 2029 | $1.857 | $1.6401 | $4.9451 | -43.38% |
| December, 2029 | $7.71 | $1.6529 | $6.8901 | +135.06% |
Voyager Therapeutics Inc Stock (VYGR) Price Forecast for 2030
Voyager Therapeutics Inc Stock (VYGR) is expected to reach an average price of $12.46 in 2030, with a high forecast of $20.37 and a low forecast of $4.5547. This signifies an +279.90% surge from the last price of $3.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.5104 | $9.2294 | $7.9924 | +128.98% |
| February, 2030 | $5.9028 | $4.5547 | $4.0028 | +79.96% |
| March, 2030 | $9.8152 | $7.7709 | $8.2652 | +199.24% |
| April, 2030 | $13.13 | $11.16 | $10.93 | +300.23% |
| May, 2030 | $13.38 | $13.66 | $13.28 | +307.87% |
| June, 2030 | $15.19 | $15.32 | $14.54 | +363.12% |
| July, 2030 | $15.72 | $14.73 | $15.24 | +379.29% |
| August, 2030 | $15.59 | $16.36 | $15.45 | +375.40% |
| September, 2030 | $14.89 | $15.80 | $15.53 | +353.98% |
| October, 2030 | $15.99 | $15.86 | $17.05 | +387.38% |
| November, 2030 | $21.55 | $16.54 | $17.63 | +556.96% |
| December, 2030 | $20.50 | $20.27 | $20.37 | +525.02% |
4.91%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):